URICOLIZ 300 MG 50 TABLETS – 2026 Price Turkey

by

Clinical Data Review: Comprehensive profile for URICOLIZ 300 MG 50 TABLETS, including its pharmacological composition, pricing in Turkey (2026), and regulatory status for international patients.

1. Pharmaceutical Profile

Proprietary Name: URICOLIZ 300 MG 50 TABLETS

Manufacturer: SANDOZ PHARMACEUTICAL INDUSTRY AND TRADE INC.

Registration Status: Licensed by T.C. Ministry of Health

Active Pharmaceutical Ingredient

ALLOPURINOL 🔗

*Click to view bioequivalent formulations.

2. Therapeutic Indications

URICOLIZ 300 MG 50 TABLETS is formulated with ALLOPURINOL, a clinically established agent in medical practice.

  • Mechanism of Action: ALLOPURINOL acts according to the pharmacological principles of its drug class to provide therapeutic relief.
  • Primary Use: Prescribed by healthcare professionals for conditions responsive to ALLOPURINOL therapy.
  • Dosage Regimen: Please refer to the official Patient Information Leaflet (PIL) included in the packaging for specific dosing instructions relative to age and severity of symptoms.

3. Market Data & Pricing (2026)

Note: Drug prices in Turkey are regulated under the Reference Pricing System (SUT) enforced by the government.

Product Name URICOLIZ 300 MG 50 TABLETS
Barcode (GTIN) 8699516012564
Generic Name ALLOPURINOL
License Holder SANDOZ PHARMACEUTICAL INDUSTRY AND TRADE INC.
Pharmacy Retail Price 307.47 TL
⚠️ Clinical Safety Warning

Do not administer URICOLIZ 300 MG 50 TABLETS if the patient has a known hypersensitivity or allergy to ALLOPURINOL. Purchase only from authorized pharmacies (Eczane) to ensure supply chain integrity.

Disclaimer: This content is compiled from public pharmaceutical records for informational purposes. It does not constitute medical advice, diagnosis, or treatment. Always consult a qualified physician regarding any medical condition.
Data Source: Product label via SANDOZ PHARMACEUTICAL INDUSTRY AND TRADE INC..

Leave a Comment